NOTICE AND INTIMATION OF 6TH AGM SCHEDULED TO BE HELD ON 29TH SEPTEMBER 2025 AT 12:30 PM THROUGH VC OR OTHER AUDIO VISUAL MEANS
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Asston Pharmaceuticals Ltd has issued notice for its 6th Annual General Meeting to be held on 29th September 2025 at 12:30 PM through video conferencing. This is the first AGM since the company's BSE listing in July 2025, where its IPO of 22.41 lakh shares was oversubscribed 186 times. For FY24-25, the company reported total revenue of Rs. 25.61 crore (up 57.28% YoY) and net profit of Rs. 3.85 crore (up 58.47% YoY). The Board has not recommended any dividend, choosing to reinvest earnings for business expansion. Foreign exchange earnings grew to Rs. 21.58 crore from Rs. 15.19 crore in the prior year.
The AGM notice is a routine compliance filing. Positives for shareholders include strong revenue and profit growth, a successful IPO oversubscription, and rising export earnings. However, the absence of a dividend may disappoint income-focused investors, though management cites reinvestment for sustainable long-term growth.